Literature DB >> 25763798

Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.

Xian-Jian Huang1,2, Olena Glushakova3, Stefania Mondello4, Ken Van2, Ronald L Hayes3, Bruce G Lyeth2.   

Abstract

A number of potential traumatic brain injury (TBI) biomarkers have been proposed and evaluated in the laboratory and clinic. This study investigated the temporal profile of circulating biomarkers of astrocytic and neuronal injury over the first 24 h and relevant histopathological changes after experimental moderate TBI. Twenty male rats were randomly assigned to either moderate parasagittal fluid percussion or sham injury. Blood serum samples were collected 2 d prior to TBI (baseline) and at 3, 6, and 24 h after TBI. A single cerebrospinal fluid (CSF) sample was collected from the cisterna magna 24 h after TBI, followed by euthanasia and brain harvesting for histology. Serum and CSF samples were analyzed for neuronal (ubiquitin carboxy-terminal hydrolase L1 [UCH-L1]) and astroglial (glial fibrillary acidic protein [GFAP]) protein levels using enzyme-linked immunosorbent assay. Brain histology included GFAP immunostaining and Fluoro-Jade histofluorescence. Serum and CSF levels of GFAP were near zero in sham animals. Serum GFAP levels were significantly elevated at 3 and 6 h post-TBI, compared with baseline and time-matched sham values, while UCH-L1 was significantly elevated only at 3 h post-TBI. Both CSF GFAP and UCH-L1 at 24 h post-TBI were significantly elevated, compared with sham. GFAP immunohistochemistry and FJ histofluorescence of degenerating neurons were performed in the same animals after 24 h survival. Histology revealed characteristic acute neuronal degeneration in the ipsilateral hippocampus and parietal cortex and reduction in GFAP immunostaining in areas of neuronal cell loss. The data provide evidence of a causal relationship between TBI-induced acute brain pathology and circulating neuronal and glial markers, further demonstrating their role as candidate markers for TBI. Studies of relative changes in biomarker levels in CSF and serum suggest that different mechanisms may underlie the transport and/or clearance of UCH-L1 and GFAP in these two compartments.

Entities:  

Keywords:  GFAP; TBI, UCH-L1; biomarkers; fluid percussion; rat

Mesh:

Substances:

Year:  2015        PMID: 25763798     DOI: 10.1089/neu.2015.3873

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  20 in total

1.  Animal Models of Posttraumatic Seizures and Epilepsy.

Authors:  Alexander V Glushakov; Olena Y Glushakova; Sylvain Doré; Paul R Carney; Ronald L Hayes
Journal:  Methods Mol Biol       Date:  2016

2.  Assessing a Blast-Related Biomarker in an Operational Community: Glial Fibrillary Acidic Protein in Experienced Breachers.

Authors:  Anna E Tschiffely; Jonathan K Statz; Katie A Edwards; Carl Goforth; Stephen T Ahlers; Walter S Carr; Jessica M Gill
Journal:  J Neurotrauma       Date:  2020-01-14       Impact factor: 5.269

3.  Do Low Serum UCH-L1 and TDP-43 Levels Indicate Disturbed Ubiquitin-Proteosome System in Autism Spectrum Disorder?

Authors:  İhsan Çetin; İhsan Tezdiğ; Mahmut Cem Tarakçioğlu; Muhammed Tayyib Kadak; Ömer Faruk Demirel; Ömer Faruk Özer; Fırat Erdoğan; Burak Doğangün
Journal:  Noro Psikiyatr Ars       Date:  2017-04-19       Impact factor: 1.339

4.  Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.

Authors:  Shenandoah Robinson; Jesse L Winer; Justin Berkner; Lindsay A S Chan; Jesse L Denson; Jessie R Maxwell; Yirong Yang; Laurel O Sillerud; Robert C Tasker; William P Meehan; Rebekah Mannix; Lauren L Jantzie
Journal:  J Neurosurg Pediatr       Date:  2016-02-19       Impact factor: 2.375

5.  Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Authors:  Robert D Welch; Morgan Ellis; Lawrence M Lewis; Syed I Ayaz; Valerie H Mika; Scott Millis; Linda Papa
Journal:  J Neurotrauma       Date:  2017-02-27       Impact factor: 5.269

6.  UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.

Authors:  Mackenzie C Morris; Aron Bercz; Grace M Niziolek; Farzaan Kassam; Rose Veile; Lou Ann Friend; Timothy A Pritts; Amy T Makley; Michael D Goodman
Journal:  J Surg Res       Date:  2019-07-03       Impact factor: 2.192

Review 7.  NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.

Authors:  Margaret J Ochocinska; Berislav V Zlokovic; Peter C Searson; A Tamara Crowder; Richard P Kraig; Julia Y Ljubimova; Todd G Mainprize; William A Banks; Ronald Q Warren; Andrei Kindzelski; William Timmer; Christina H Liu
Journal:  Fluids Barriers CNS       Date:  2017-05-01

8.  Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid.

Authors:  Angela M Boutté; Vivian Hook; Bharani Thangavelu; George Anis Sarkis; Brittany N Abbatiello; Gregory Hook; J Steven Jacobsen; Claudia S Robertson; Janice Gilsdorf; Zhihui Yang; Kevin K W Wang; Deborah A Shear
Journal:  J Neurotrauma       Date:  2020-04-02       Impact factor: 5.269

Review 9.  Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction.

Authors:  Venkata S S S Sajja; Nora Hlavac; Pamela J VandeVord
Journal:  Front Integr Neurosci       Date:  2016-02-29

10.  Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.

Authors:  Jin Lei; Guoyi Gao; Junfeng Feng; Yichao Jin; Chuanfang Wang; Qing Mao; Jiyao Jiang
Journal:  Crit Care       Date:  2015-10-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.